Register of Class 2 Cell, Tissue or Gene Therapy Products

Find information on currently registered cell, tissue or gene therapy products (CTGTP) in Singapore.

Product Name	Active Ingredient(s)	Product Registration Number	Registrant	Approval Date	Approved Package Insert (PI)/ Patient Information Leaflet (PIL)
KYMRIAH^® cells dispersion for infusion	Tisagenlecleucel	CTGT0001P	Novartis (Singapore) Pte Ltd	2021/03/03	Kymriah PI approved 4 January 2023
LUXTURNA^® 5x10¹² vector genomes/ml Concentrate and Solvent for Solution for Injection	Voretigene neparvovec	CTGT0002P	Novartis (Singapore) Pte Ltd	2022/01/20	Luxturna PI approved 19 April 2023 Luxturna PIL approved 20 January 2022
YESCARTA^® suspension for intravenous infusion	Axicabtagene ciloleucel	CTGT0003P	Gilead Sciences Singapore Pte Ltd	2023/03/01	Yescarta PI approved 01 March 2023 Yescarta PIL approved 01 March 2023
ZOLGENSMA^® Suspension for intravenous infusion	Onasemnogene abeparvovec	CTGT0004P	Novartis (Singapore) Pte Ltd	2023/04/21	Zolgensma PI approved 18 July 2023

Last updated: 31 Dec 2018